Contract facts
UnrestrictedINTRANASAL TREATMENT FOR MILD TRAUMATIC BRAIN INJURY (BROAD AGENCY ANNOUNCEMENT NUMBER SO190192) is a federal Unrestricted award for Army Med Res Acq Activity held by Beyond Barriers Therapeutics, Inc. Estimated value $1.9M ($1.9M obligated). Current period of performance ends Jan 24, 2027. Place of performance: GLENCOE IL. Related solicitation W81XWH18SSOC1.
INTRANASAL TREATMENT FOR MILD TRAUMATIC BRAIN INJURY (BROAD AGENCY ANNOUNCEMENT NUMBER SO190192)
Recompete timing
PublicCurrent PoP ends Jan 24, 2027 (119 days remaining). Agencies typically plan 12–18 months ahead — at 3.9 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on HT942523C0036? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordBeyond Barriers Therapeutics, Inc — $879K obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942523C0036?
HT942523C0036 (Intranasal treatment for MILD traumatic BRAIN) is a Army Med Res Acq Activity award with a potential value of $1.9M, currently held by Beyond Barriers Therapeutics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9425-23-C-0036?
HT9425-23-C-0036 is the dashed form of PIID HT942523C0036 (Intranasal treatment for MILD traumatic BRAIN), held by Beyond Barriers Therapeutics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT942523C0036?
Army Med Res Acq Activity awarded HT942523C0036 to Beyond Barriers Therapeutics, Inc (potential $1.9M).
Who is the incumbent on HT942523C0036?
Beyond Barriers Therapeutics, Inc is the incumbent with $879K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Jan 24, 2027.
When does Beyond Barriers Therapeutics, Inc’s HT942523C0036 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 24, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT942523C0036? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.